Proof-of-Principle Study Suggesting Potential Anti-Inflammatory Activity of Butyrate and Propionate in Periodontal Cells.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study with no human or animal clinical data
PubMed 36232340 · doi:10.3390/ijms231911006
What was done
Researchers evaluated the anti-inflammatory potential of short-chain fatty acids (acetate, propionate, and butyrate) across multiple cell culture models. RAW 264.7 and primary macrophages were stimulated with Porphyromonas gingivalis lipopolysaccharide (LPS) in the presence or absence of short-chain fatty acids. Gingival fibroblasts and HSC2 oral epithelial cells were stimulated with IL1β and TNFα with or without short-chain fatty acids. Gene expression of inflammatory cytokines/chemokines (IL6, IL8, CXCL1, CXCL2) and NF-κB p65 nuclear translocation were evaluated.
What was found
The abstract reports directional findings without numerical values or effect sizes. Butyrate reduced LPS-induced expression of IL6 and CXCL2 in RAW 264.7 and primary macrophages. In gingival fibroblasts, butyrate reduced IL1β/TNFα-induced IL8, CXCL1, and CXCL2 expression. In HSC2 epithelial cells, butyrate reduced CXCL1 and CXCL2 expression, but did not alter IL8 expression. Butyrate also decreased p65 nuclear translocation in RAW 264.7 cells, gingival fibroblasts, and HSC2 cells. Propionate and acetate partially lowered inflammatory responses, but changes did not reach statistical significance.
Why it matters
The findings demonstrate that butyrate acts directly on both resident immune cells and non-immune structural cells of the periodontium to attenuate inflammatory signaling, potentially mediated via inhibition of the NF-κB pathway.
Limits
This is an in vitro study limited to isolated cell lines and primary cells, lacking in vivo physiological complexity, salivary clearance, and tissue-level microbiome interactions. The abstract does not report sample sizes, concentrations tested, exact quantitative data, confidence intervals, or p-values. Propionate and acetate failed to achieve statistically significant anti-inflammatory effects under the tested conditions.
Cited by
- supports In vitro studies show that applying ellagic acid or microbiome short-chain fatty acids to cultured inflammatory cells suppresses inflammatory activation.